Avoid common mistakes on your manuscript.
Correction to: Journal of Cancer Research and Clinical Oncology https://doi.org/10.1007/s00432-021-03769-2
In the original article published, there are several corrections in the author names published in the author group. The corrections are mentioned below:
The given name of the 1st author is Simona and the family name is Jurkovic Mlakar.
The first name of the 2nd author is Satyanarayana Chakradhara Rao and the family name is Uppugunduri.
The author name Mohammed Aziz Rezgui incorrectly published as Mohamed-Ali Rezgui.
In addition, the affiliation number 2 has been changed from University Hospital of Geneva into “Geneva University Hospitals and University of Geneva”, because of just recent official changes at the university.
The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jurkovic Mlakar, S., Uppugunduri, S.C.R., Nava, T. et al. Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. J Cancer Res Clin Oncol 148, 87–88 (2022). https://doi.org/10.1007/s00432-021-03830-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-021-03830-0